Literature DB >> 33262135

Composition, Spatial Characteristics, and Prognostic Significance of Myeloid Cell Infiltration in Pancreatic Cancer.

Jonathan A Nowak1,2, Brian M Wolpin3, Sara A Väyrynen4, Jinming Zhang4, Chen Yuan4, Juha P Väyrynen4,5,6, Andressa Dias Costa4, Hannah Williams4, Vicente Morales-Oyarvide4, Mai Chan Lau5, Douglas A Rubinson4, Richard F Dunne7, Margaret M Kozak8, Wenjia Wang7, Diana Agostini-Vulaj9, Michael G Drage9, Lauren Brais4, Emma Reilly4, Osama Rahma4,10, Thomas Clancy11, Jiping Wang11, David C Linehan12, Andrew J Aguirre4,13, Charles S Fuchs14,15,16, Lisa M Coussens17,18, Daniel T Chang8, Albert C Koong19, Aram F Hezel7, Shuji Ogino5,13,20,21.   

Abstract

PURPOSE: Although abundant myeloid cell populations in the pancreatic ductal adenocarcinoma (PDAC) microenvironment have been postulated to suppress antitumor immunity, the composition of these populations, their spatial locations, and how they relate to patient outcomes are poorly understood. EXPERIMENTAL
DESIGN: To generate spatially resolved tumor and immune cell data at single-cell resolution, we developed two quantitative multiplex immunofluorescence assays to interrogate myeloid cells (CD15, CD14, ARG1, CD33, HLA-DR) and macrophages [CD68, CD163, CD86, IFN regulatory factor 5, MRC1 (CD206)] in the PDAC tumor microenvironment. Spatial point pattern analyses were conducted to assess the degree of colocalization between tumor cells and immune cells. Multivariable-adjusted Cox proportional hazards regression was used to assess associations with patient outcomes.
RESULTS: In a multi-institutional cohort of 305 primary PDAC resection specimens, myeloid cells were abundant, enriched within stromal regions, highly heterogeneous across tumors, and differed by somatic genotype. High densities of CD15+ARG1+ immunosuppressive granulocytic cells and M2-polarized macrophages were associated with worse patient survival. Moreover, beyond cell density, closer proximity of M2-polarized macrophages to tumor cells was strongly associated with disease-free survival, revealing the clinical significance and biologic importance of immune cell localization within tumor areas.
CONCLUSIONS: A diverse set of myeloid cells are present within the PDAC tumor microenvironment and are distributed heterogeneously across patient tumors. Not only the densities but also the spatial locations of myeloid immune cells are associated with patient outcomes, highlighting the potential role of spatially resolved myeloid cell subtypes as quantitative biomarkers for PDAC prognosis and therapy. ©2020 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2020        PMID: 33262135      PMCID: PMC8345232          DOI: 10.1158/1078-0432.CCR-20-3141

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  52 in total

1.  Cancer statistics, 2019.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2019-01-08       Impact factor: 508.702

2.  FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.

Authors:  Thierry Conroy; Pascal Hammel; Mohamed Hebbar; Meher Ben Abdelghani; Alice C Wei; Jean-Luc Raoul; Laurence Choné; Eric Francois; Pascal Artru; James J Biagi; Thierry Lecomte; Eric Assenat; Roger Faroux; Marc Ychou; Julien Volet; Alain Sauvanet; Gilles Breysacher; Frédéric Di Fiore; Christine Cripps; Petr Kavan; Patrick Texereau; Karine Bouhier-Leporrier; Faiza Khemissa-Akouz; Jean-Louis Legoux; Béata Juzyna; Sophie Gourgou; Christopher J O'Callaghan; Claire Jouffroy-Zeller; Patrick Rat; David Malka; Florence Castan; Jean-Baptiste Bachet
Journal:  N Engl J Med       Date:  2018-12-20       Impact factor: 91.245

3.  Tumor-associated macrophages exhibit pro- and anti-inflammatory properties by which they impact on pancreatic tumorigenesis.

Authors:  Ole Helm; Janka Held-Feindt; Evelin Grage-Griebenow; Norbert Reiling; Hendrik Ungefroren; Ilka Vogel; Uwe Krüger; Thomas Becker; Michael Ebsen; Christoph Röcken; Dieter Kabelitz; Heiner Schäfer; Susanne Sebens
Journal:  Int J Cancer       Date:  2014-02-05       Impact factor: 7.396

Review 4.  Macrophage Polarization.

Authors:  Peter J Murray
Journal:  Annu Rev Physiol       Date:  2016-10-21       Impact factor: 19.318

5.  The prognostic value of tumour-infiltrating lymphocytes in pancreatic cancer: a systematic review and meta-analysis.

Authors:  Adile Orhan; Rasmus P Vogelsang; Malene B Andersen; Michael T Madsen; Emma R Hölmich; Hans Raskov; Ismail Gögenur
Journal:  Eur J Cancer       Date:  2020-04-22       Impact factor: 9.162

Review 6.  From state-of-the-art treatments to novel therapies for advanced-stage pancreatic cancer.

Authors:  Christopher Nevala-Plagemann; Manuel Hidalgo; Ignacio Garrido-Laguna
Journal:  Nat Rev Clin Oncol       Date:  2019-11-08       Impact factor: 66.675

7.  Association of Alterations in Main Driver Genes With Outcomes of Patients With Resected Pancreatic Ductal Adenocarcinoma.

Authors:  Zhi Rong Qian; Douglas A Rubinson; Jonathan A Nowak; Vicente Morales-Oyarvide; Richard F Dunne; Margaret M Kozak; Marisa W Welch; Lauren K Brais; Annacarolina Da Silva; Tingting Li; Wanwan Li; Atsuhiro Masuda; Juhong Yang; Yan Shi; Mancang Gu; Yohei Masugi; Justin Bui; Caitlin L Zellers; Chen Yuan; Ana Babic; Natalia Khalaf; Andrew Aguirre; Kimmie Ng; Rebecca A Miksad; Andrea J Bullock; Daniel T Chang; Jennifer F Tseng; Thomas E Clancy; David C Linehan; Jennifer J Findeis-Hosey; Leona A Doyle; Aaron R Thorner; Matthew Ducar; Bruce Wollison; Angelica Laing; William C Hahn; Matthew Meyerson; Charles S Fuchs; Shuji Ogino; Jason L Hornick; Aram F Hezel; Albert C Koong; Brian M Wolpin
Journal:  JAMA Oncol       Date:  2018-03-08       Impact factor: 31.777

8.  Accumulation of FOXP3+T-cells in the tumor microenvironment is associated with an epithelial-mesenchymal-transition-type tumor budding phenotype and is an independent prognostic factor in surgically resected pancreatic ductal adenocarcinoma.

Authors:  Martin Wartenberg; Inti Zlobec; Aurel Perren; Viktor Hendrik Koelzer; Beat Gloor; Alessandro Lugli; Eva Karamitopoulou
Journal:  Oncotarget       Date:  2015-02-28

9.  Comparative characterization of stroma cells and ductal epithelium in chronic pancreatitis and pancreatic ductal adenocarcinoma.

Authors:  Ole Helm; Ruben Mennrich; Domantas Petrick; Lisa Goebel; Sandra Freitag-Wolf; Christian Röder; Holger Kalthoff; Christoph Röcken; Bence Sipos; Dieter Kabelitz; Heiner Schäfer; Hans-Heinrich Oberg; Daniela Wesch; Susanne Sebens
Journal:  PLoS One       Date:  2014-05-05       Impact factor: 3.240

10.  Differential association of CD68+ and CD163+ macrophages with macrophage enzymes, whole tumour gene expression and overall survival in advanced melanoma.

Authors:  Patrick F Forde; Cynthia C B B Heffron; Liam Friel Tremble; Mark McCabe; Sidney P Walker; Siobhán McCarthy; Réiltín F Tynan; Suzanne Beecher; Réiltín Werner; A James P Clover; X Derek G Power
Journal:  Br J Cancer       Date:  2020-08-26       Impact factor: 9.075

View more
  19 in total

1.  Single-nucleus and spatial transcriptome profiling of pancreatic cancer identifies multicellular dynamics associated with neoadjuvant treatment.

Authors:  William L Hwang; Karthik A Jagadeesh; Jimmy A Guo; Hannah I Hoffman; Payman Yadollahpour; Jason W Reeves; Rahul Mohan; Eugene Drokhlyansky; Nicholas Van Wittenberghe; Orr Ashenberg; Samouil L Farhi; Denis Schapiro; Prajan Divakar; Eric Miller; Daniel R Zollinger; George Eng; Jason M Schenkel; Jennifer Su; Carina Shiau; Patrick Yu; William A Freed-Pastor; Domenic Abbondanza; Arnav Mehta; Joshua Gould; Conner Lambden; Caroline B M Porter; Alexander Tsankov; Danielle Dionne; Julia Waldman; Michael S Cuoco; Lan Nguyen; Toni Delorey; Devan Phillips; Jaimie L Barth; Marina Kem; Clifton Rodrigues; Debora Ciprani; Jorge Roldan; Piotr Zelga; Vjola Jorgji; Jonathan H Chen; Zackery Ely; Daniel Zhao; Kit Fuhrman; Robin Fropf; Joseph M Beechem; Jay S Loeffler; David P Ryan; Colin D Weekes; Cristina R Ferrone; Motaz Qadan; Martin J Aryee; Rakesh K Jain; Donna S Neuberg; Jennifer Y Wo; Theodore S Hong; Ramnik Xavier; Andrew J Aguirre; Orit Rozenblatt-Rosen; Mari Mino-Kenudson; Carlos Fernandez-Del Castillo; Andrew S Liss; David T Ting; Tyler Jacks; Aviv Regev
Journal:  Nat Genet       Date:  2022-07-28       Impact factor: 41.307

2.  Tumor Cells Modulate Macrophage Phenotype in a Novel In Vitro Co-Culture Model of the NSCLC Tumor Microenvironment.

Authors:  Josiah Voth Park; Raghav Chandra; Ling Cai; Debolina Ganguly; Huiyu Li; Jason E Toombs; Luc Girard; Rolf A Brekken; John D Minna
Journal:  J Thorac Oncol       Date:  2022-07-05       Impact factor: 20.121

Review 3.  Translational advances in pancreatic ductal adenocarcinoma therapy.

Authors:  Abdel Nasser Hosein; Stephanie K Dougan; Andrew J Aguirre; Anirban Maitra
Journal:  Nat Cancer       Date:  2022-03-29

4.  Systemic Delivery of Oncolytic Adenovirus to Tumors Using Tumor-Infiltrating Lymphocytes as Carriers.

Authors:  Joao Santos; Camilla Heiniö; Dafne Quixabeira; Sadia Zafar; James Clubb; Santeri Pakola; Victor Cervera-Carrascon; Riikka Havunen; Anna Kanerva; Akseli Hemminki
Journal:  Cells       Date:  2021-04-22       Impact factor: 6.600

5.  Immune cell profiles in the tumor microenvironment of early-onset, intermediate-onset, and later-onset colorectal cancer.

Authors:  Tomotaka Ugai; Jennifer Borowsky; Marios Giannakis; Shuji Ogino; Juha P Väyrynen; Mai Chan Lau; Naohiko Akimoto; Sara A Väyrynen; Melissa Zhao; Rong Zhong; Koichiro Haruki; Andressa Dias Costa; Kenji Fujiyoshi; Kota Arima; Kana Wu; Andrew T Chan; Yin Cao; Mingyang Song; Charles S Fuchs; Molin Wang; Jochen K Lennerz; Kimmie Ng; Jeffrey A Meyerhardt; Jonathan A Nowak
Journal:  Cancer Immunol Immunother       Date:  2021-09-16       Impact factor: 6.630

6.  spatialTIME and iTIME: R package and Shiny application for visualization and analysis of immunofluorescence data.

Authors:  Jordan H Creed; Christopher M Wilson; Alex C Soupir; Christelle M Colin-Leitzinger; Gregory J Kimmel; Oscar E Ospina; Nicholas H Chakiryan; Joseph Markowitz; Lauren C Peres; Anna Coghill; Brooke L Fridley
Journal:  Bioinformatics       Date:  2021-11-04       Impact factor: 6.931

7.  Radiation combines with immune checkpoint blockade to enhance T cell priming in a murine model of poorly immunogenic pancreatic cancer.

Authors:  Courtney T Stump; Kevin Roehle; Nataly Manjarrez Orduno; Stephanie K Dougan
Journal:  Open Biol       Date:  2021-11-17       Impact factor: 6.411

8.  Integrated analysis of immune infiltration in esophageal carcinoma as prognostic biomarkers.

Authors:  Hang Yin; Xiaoyuan Wang; Nannan Jin; Xiaodong Ling; Xue Leng; Yu Wang; Keru Ma; Xiangyu Jiang; Jinhong Zhu; Jianqun Ma
Journal:  Ann Transl Med       Date:  2021-11

9.  Leukocyte Heterogeneity in Pancreatic Ductal Adenocarcinoma: Phenotypic and Spatial Features Associated with Clinical Outcome.

Authors:  Shannon M Liudahl; Courtney B Betts; Shamilene Sivagnanam; Jonathan A Nowak; Brian M Wolpin; Lisa M Coussens; Vicente Morales-Oyarvide; Annacarolina da Silva; Chen Yuan; Samuel Hwang; Alison Grossblatt-Wait; Kenna R Leis; William Larson; Meghan B Lavoie; Padraic Robinson; Andressa Dias Costa; Sara A Väyrynen; Thomas E Clancy; Douglas A Rubinson; Jason Link; Dove Keith; Wesley Horton; Margaret A Tempero; Robert H Vonderheide; Elizabeth M Jaffee; Brett Sheppard; Jeremy Goecks; Rosalie C Sears; Byung S Park; Motomi Mori
Journal:  Cancer Discov       Date:  2021-03-16       Impact factor: 39.397

Review 10.  Challenges and Opportunities in the Statistical Analysis of Multiplex Immunofluorescence Data.

Authors:  Christopher M Wilson; Oscar E Ospina; Mary K Townsend; Jonathan Nguyen; Carlos Moran Segura; Joellen M Schildkraut; Shelley S Tworoger; Lauren C Peres; Brooke L Fridley
Journal:  Cancers (Basel)       Date:  2021-06-17       Impact factor: 6.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.